Forms: Download Registration Form in either: Microsoft Word or Adobe PDF format
Held On: December 4 - 5, 2006
Location:
Hilton Newark Airport
1170 Spring Street, Elizabeth, NJ 07201-2114

Overview

Obesity is a serious condition that is associated with and believed to cause much morbidity, reduced quality of life, and decreased longevity. The most recent figures from the Centers for Disease Control indicate that obesity continues to increase in prevalence in the overall US population. Currently available treatments are only modestly efficacious and rigorously evaluating new (and in some cases existing) treatments for obesity are clearly in order. Conducting such evaluations to the highest standards and so that they are maximally informative requires an understanding of best methods for the conduct of randomized clinical trials in general and how they can be tailored to the specific needs of obesity research in particular. In response to recent Medicare calls for increased evaluation of obesity treatments, an FDA meeting on open questions in the conduct of obesity treatment trials, and high profile editorials in general medical journals questioning the way we design, execute, analyze, and interpret randomized clinical trials in obesity research, we will offer a two-day meeting in which leading obesity researchers and methodologists convene to discuss best practices for randomized clinical trials in obesity.

Women, members of underrepresented minority groups and individuals with disabilities are strongly encouraged to apply.

Tuition is $100 for attendees from academic, government, and not-for-profit organizations and $850 for attendees from for-profit companies and does not include the cost of food, travel or lodging. Limited funds are available on a competitive basis for travel scholarships with preference given to graduate students and post-doctoral fellows.

Registration will be limited to 100, so please apply prior to Sun 10/15/2006. Accepted applicants will be notified by Fri 10/20/2006.

Schedule of Events

Speakers

Contact Information:

Logistics: This email address is being protected from spambots. You need JavaScript enabled to view it.
Scientific: This email address is being protected from spambots. You need JavaScript enabled to view it.

Funding for this conference was made possible (in part) by (1 R13 DK077555-01) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Cancer Institute (NCI). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S Government.